Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
High affinity receptor for urotensin-2 and urotensin-2B. Additionally we are shipping Urotensin 2 Receptor Kits (4) and and many more products for this protein.
Showing 10 out of 57 products:
Human Polyclonal UTS2R Primary Antibody for EIA, WB - ABIN955483
Gould, Gu, Liao, Ahmad, Cudmore, Ahmed, Vatish: Upregulation of urotensin II receptor in preeclampsia causes in vitro placental release of soluble vascular endothelial growth factor receptor 1 in hypoxia. in Hypertension 2010
Show all 5 references for 955483
UII (show UTS2 Antibodies)/GPR14 signaling was involved in the DSS (show NR0B1 Antibodies)-induced colonic inflammation and its inhibition may serve as a potential therapeutic target, which may be associated with the NF-kappaB (show NFKB1 Antibodies) signaling pathway.
Urotensin II (show UTS2 Antibodies) can induce the proliferation of BEL (show LHX2 Antibodies)-7402 cells via the urotensin receptor mediated PKC (show PRRT2 Antibodies)/ERK/p38 MAPK (show MAPK1 Antibodies) signaling pathways.
Report interaction of urantide with urotensin II receptor.
UTR protein and mRNA levels were increased in colon cancer cell lines and in colon adenoma and adenocarcinoma. UTR appears to be involved in the regulation of colon cancer cell invasion and motility.
High UTR expression is an independent prognostic factor of good prognosis for non muscle invasive bladder transitional cancer.
family-based analysis of association between blood pressure, glomerular filtration and genes of the urotensin-II (show UTS2 Antibodies) pathway (urotensin-II (show UTS2 Antibodies), urotensin-II related peptide, urotensin-II receptor) saturated with 28 tagging single nucleotide polymorphisms
Data suggest that UTS2R in aortic endothelium is involved in development of diabetes-associated atherosclerosis; diabetes-associated plaque development is attenuated by urotensin II (show UTS2 Antibodies)/UTS2R antagonism in in vitro setting.
Data show that vasoactive peptide urotensin II receptor and GABA(A)R are co-expressed in cerebellar glial cells from rat brain slices, in human native astrocytes and in glioma cell line.
Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells.
hUII may deteriorate monocrotaline-induced cardiac hypertrophy mainly through a vasoconstriction of the pulmonary artery and partly through the suppression of ANP (show NPPA Antibodies) secretion.
UII (show UTS2 Antibodies)/UTR system plays a role in lipopolysaccharide (LPS (show TLR4 Antibodies))/D-galactosamine (GalN (show GAL Antibodies))-induced acute liver failure.
findings demonstrate an important role for UII (show UTS2 Antibodies) in the pathogenesis of the metabolic syndrome and suggest that the use of UT receptor antagonists may provide a new therapeutic tool for the treatment of this syndrome
a new urotensin II receptor signalling pathway which is mediated by EGFR (show EGFR Antibodies) trans-activation, dependent by beta-arrestin 1 (show ARRB1 Antibodies)/2, promoting cell survival and cardioprotection.
In addition to its role at the neuromuscular junction, urotensin II (show UTS2 Antibodies) may control motor function through the modulation of motoneuron activity within the spinal cord.
the up-regulation of vascular U-II (show UTS2 Antibodies) receptor (UT), GPR14 might be involved in the pathogenesis of atherosclerosis.
Elevated expression of Uts2r in skeletal muscle of diabetic mouse is repoted.
Urotensin II receptor knockout mice on an ApoE (show APOE Antibodies) knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
The role of urotensin 2 (show UTS2 Antibodies) and urotensin 2 (show UTS2 Antibodies) receptors in the skeletal muscle fat accumulation and fatty acid metabolism, thus indicating their potential pathological functions related to obesity and type 2 diabetes in humans.
High affinity receptor for urotensin-2 and urotensin-2B. The activity of this receptor is mediated by a G-protein that activate a phosphatidylinositol-calcium second messenger system.
urotensin 2 receptor
, G protein-coupled receptor
, urotensin II receptor
, urotensin-2 receptor
, G protein-coupled receptor 14
, G-protein coupled receptor 14
, G-protein coupled sensory epithelial neuropeptide-like receptor
, putative G protein-coupled receptor (SENR)
, urotensin receptor
, UT receptor